Claes Held holds a senior consultant faculty position at Dept of Cardiology, Uppsala University Hospital and Uppsala Clinical Research Center (UCR).
He has published around 150 papers in peer-reviewed international journals. His research has mainly focused on treatments and clinical prognostication of patients with ACS and stable coronary heart disease (CHD) and biomarker research, as well as in trials evaluating antithrombotic treatment in ACS or patients with atrial fibrillation. He is also involved in research on potential links between psycho-social risk factors and risk of suffering ACS, as well as cognitive behavioral therapy post-MI.
He is a member of the Steering Committee in RIKS-HIA registry (part of Swedeheart). He has been involved in developing the Swedeheart Quality Index and published several papers using data from the registry. He is also involved in several of the completed and ongoing registry-based RCTs.